Sébastien Lacroix-Desmazes (Sebastien Lacroix-Desmazes)

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 4

Top Topics

Inflammatory Response

Ejection Fraction

End Stage Renal Disease

Top Venues

Haemophilia : the official journal of the World Federation of Hemophilia

Nature medicine

European journal of rheumatology

This page only lists publications with an associated author ORCID identifier.

Publications

Shannon L Meeks, Sébastien Lacroix-Desmazes
Emerging benefits of Fc fusion technology in the context of recombinant factor VIII replacement therapy. Haemophilia : the official journal of the World Federation of Hemophilia 26 (6) (2020)
Kathleen P Pratt, Valder R Arruda, Sébastien Lacroix-Desmazes
Inhibitors-Recent insights. Haemophilia : the official journal of the World Federation of Hemophilia (2020)
Christian Leborgne, Elena Barbon, Jeffrey M Alexander, Hayley Hanby, Sandrine Delignat, Daniel M Cohen, Fanny Collaud, Saghana Muraleetharan, Dan Lupo, Joseph Silverberg, Karen Huang, Laetitia van Wittengerghe, Béatrice Marolleau, Adeline Miranda, Anna Fabiano, Victoria Daventure, Heena Beck, Xavier M Anguela, Giuseppe Ronzitti, Sean M Armour, Sébastien Lacroix-Desmazes, Federico Mingozzi
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nature medicine 26 (7) (2020)
Vandana Pradhan, Pallavi Pandit, Prathamesh Surve, Maxime Lecerf, Anjali M Rajadhyaksha, Milind Nadkar, Prasad V Khadilkar, Durga A Chougule, Aalaap A Naigaonkar, Sébastien Lacroix-Desmazes, Jagadeesh Bayry, Kanjaksha Ghosh, Srini V Kaveri
Catalytic antibodies in patients with systemic lupus erythematosus. European journal of rheumatology 5 (3) (2018)